Nasopore FD fragmentable nasal dressing, Catalog Numbers 5400-020-108 and 5400-020-108ITL

FDA Device Recall #Z-1476-2025 — Class II — February 25, 2025

Recall Summary

Recall Number Z-1476-2025
Classification Class II — Moderate risk
Date Initiated February 25, 2025
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Stryker Corporation
Location Portage, MI
Product Type Devices
Quantity 182,344 total units

Product Description

Nasopore FD fragmentable nasal dressing, Catalog Numbers 5400-020-108 and 5400-020-108ITL

Reason for Recall

There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that the sterility seal has been breached.

Distribution Pattern

US Nationwide distribution.

Lot / Code Information

5400-020-108 UDI-DI: 07613327117226, Lot Numbers: 2023011317 2023021717 2023030932 2023040317 2023083017 2023102517 2024020517 2024080717; 5400-020-108ITL UDI-DI: 07613327117226, Lot Numbers: 2023012017 2023032817 2023042017 2023091117 2023111417 2023120517 2024011817 2023020732 2023041117 2023062017 2023092017 2023112017 2024010817 2024012417 2023031717 2023041417 2023082317 2023103117 2023112817 2024011217

Other Recalls from Stryker Corporation

Recall # Classification Product Date
Z-2282-2026 Class II Neptune Smart Docking Station (120V), Catalog N... May 6, 2026
Z-2166-2026 Class II Thermedx FluidSmart Urology Tube Set REF LL0006... Apr 9, 2026
Z-1427-2026 Class II MOLLI 2 System System includes: MM1000 (Pack ... Jan 21, 2026
Z-0601-2026 Class II NICO BrainPath; Product Number/Product Name ... Oct 31, 2025
Z-0599-2026 Class II NICO Myriad Handpiece Product Number/Product... Oct 31, 2025

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.